The World Patient Safety Congress Europe will bring together drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches and discuss how you can tackle the challenges of social media and drug safety legislation globally at the World Patient Safety Congress.
The congress is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.
Wednesday 23th September
Session from speaker: AstraZeneca
Session from speaker: GSK
Session from speaker: ArisGlobal & Johnson & Johnson
Session from speaker: GSK, MHRA and Grunethal
Session from speaker: Veeva and Sandoz
Session from speaker: AstraZeneca
Session from speaker: Parexel
Wednesday 24th September
Session from speaker: Bristol Myers Squibb
Session from speaker: Johnson & Johnson
Session from speaker: Tata Consultancy Services
Session from speaker: Insmed, PrimeVigilance and Argenx
Session from speaker: Accenture
Session from speaker: RxLogix
Session from speaker: AbbVie, Eisai, MHRA, Health Canada and MSD